- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07248657
Comprehensive Therapeutic Program For People With Multiple Sclerosis (BIB_MS)
Study Overview
Status
Intervention / Treatment
Detailed Description
Multiple sclerosis (MS) is a chronic neurological disease predominantly affecting young adults and often leads to significant limitations in both professional and social life. Current therapeutic approaches apart from pharmacotherapy, emphasize non-pharmacological interventions, rehabilitation, and holistic lifestyle modifications (Duan, 2023).
This study provides individuals with MS the opportunity to participate in an intensive 4-month single-arm therapeutic program that combines specialized outpatient physiotherapy, psychotherapy, and nutritional counseling. The physiotherapy component is based on a scientifically validated approach-Motor Program Activating Therapy-which directly targets motor control and central nervous system function (Řasová, 2015).The program was developed by two physiotherapists specializing in MS during their doctoral studies (Procházková, 2020; Prokopiusová, 2020), whose research focused on factors influencing disease progression and the efficacy of physiotherapeutic interventions. In this prospective study participants will undergo outpatient program aiming to enhance neuroplasticity, improve physical and psychological functions, physical performance and contribute to long-term health maintenance.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kamila Rasova, prof.
- Phone Number: +420604511416
- Email: kamila.rasova@gmail.com
Study Contact Backup
- Name: Barbora Miznerova, MD
- Phone Number: +420776480210
- Email: barbora.miznerova@ftn.cz
Study Locations
-
-
-
Prague, Czechia
- Assossiation for Body in Balance
-
Contact:
- Terezie Prokopiusova, Mgr., Ph.D.
- Phone Number: +420 737 449 662
- Email: protelovrovnovaze@gmail.com
-
Contact:
- Marie Prochazkova, Mgr., Ph.D.
- Email: prochazkova777@gmail.com
-
Principal Investigator:
- Barbora Miznerova, MD.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Confirmed clinical diagnosis of MS
- Age ≤ 75 years
- Predominantly motor impairment
- EDSS 2-8
- Ability and motivation to attend outpatient physiotherapy regularly
Exclusion criteria:
• Contraindications such as severe orthopedic or cardiovascular dysfunction, or presence of another neurological disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: COMPREHENSIVE THERAPEUTIC PROGRAM FOR PEOPLE WITH MULTIPLESCLEROSIS
This is a prospective single-arm study. Participants will undergo a four-month rehabilitation program consisting of physiotherapy sessions twice per week for the first two months (50 minutes each), once weekly during the third month, and once every two weeks in the fourth month. All participants will receive a combined outpatient intervention consisting of individually tailored physiotherapy and group psychotherapy. Physiotherapy will focus on posture correction, movement control, and functional mobility using the Motor Program Activating Therapy method, complemented by Dynamic Muscular Stabilization, manual, and soft-tissue techniques. Additionally, participants will attend three 90-minute group psychotherapy sessions aimed at supporting mental well-being, stress management, and motivation during rehabilitation, including education on coping strategies, relaxation, and nutrition. |
Physiotherapy sessions will be individually tailored according to each participant's goals.
Soft tissue and joint techniques will be used as needed to prepare the body for optimal posture activation in sitting, standing, walking, and other movements.
Therapists will use reflex, mobilization, and soft-tissue techniques.
The Motor Program Activating Therapy method will be the primary approach, complemented by Dynamic Muscular Stabilization and movement self-awareness techniques.
In addition, all participants will attend three 90-minute group psychotherapy sessions led by a psychologist.
These sessions will support mental well-being, stress management, and motivation throughout the physiotherapy process.
Participants will learn practical coping strategies for emotions, pain, and psychological strain.
Relaxation techniques will be demonstrated and practiced, and basic nutritional recommendations will be provided in written or online form.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Nine Hole Peg test (NHPT)
Time Frame: Baseline and 4 months
|
measures speed (in seconds) of this fine hand movement task
|
Baseline and 4 months
|
|
The Four Square Step Test (FSST)
Time Frame: baseline and endpoint at 4 months
|
Time (in seconds) to reach clockwise and counterclockwise stepping task
|
baseline and endpoint at 4 months
|
|
The 2-Minute Walking Test (2MWT)
Time Frame: baseline and endpoint at 4 months
|
The distance one is able walk in two minutes, including noting stops needed and mobility aids (e.g., crutches, canes, or walkers)
|
baseline and endpoint at 4 months
|
|
The Symbol Digit Modalities Test (SDMT)
Time Frame: baseline and endpoint at 4 months
|
A brief neuropsychological test assessing attention, visual scanning, processing speed, and working memory.
Participants match symbols to numbers according to a reference key within a limited time - 90 seconds - the final score is result
|
baseline and endpoint at 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multiple Sclerosis Impact Scale (MSIS-29)
Time Frame: baseline and end-point at 4 months
|
Questionnaires to measure the physical and the psychological impact of multiple sclerosis form the patient's perspective.
|
baseline and end-point at 4 months
|
|
Modified Fatigue Impact Scale (MFIS)
Time Frame: baseline and end-point at 4 months
|
Questoionnaire to assess impact of fatigue on namely tasks and life situations in PwMS.
|
baseline and end-point at 4 months
|
|
Activities-Specific Balance Confidence Scale (ABC scale)
Time Frame: baseline and end-point at 4 months
|
Participants: For each of the following activities, please indicate your level of confidence in doing the activity without losing balance.
The confidence is assessed in percentage, and all results are finally averaged.
|
baseline and end-point at 4 months
|
|
International Classification of Functioning, Disability and Health (ICF) assessment
Time Frame: baseline and 4 months
|
Brief core set for Multiple Sclerosis is used to assess the participant's situation with use of the ICF
|
baseline and 4 months
|
|
tremor assessment
Time Frame: baseline and 4 months
|
Assessment of tremor of upper limbs while holding one arm forward for 60 seconds.
Measured with closed and opened eyes by accelerometer. he spectral characteristic of postural tremor measured by the 3-axis accelerometer and 3-axis gyroscope chip (Motion Tracking sensor MPU-6050) - lower value, lower tremor.
|
baseline and 4 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Autoimmune Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Behavior
- Multiple Sclerosis
- Motor Activity
- Inhibition, Psychological
- Psychotherapy
- Behavioral Disciplines and Activities
- Socioenvironmental Therapy
- Psychotherapy, Group
Other Study ID Numbers
- UK3LF/57 1290 12025-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Outpatient physiotherapy
-
Tan Tock Seng HospitalCompleted
-
Charles University, Czech RepublicRecruitingChronic Low-back PainCzechia
-
University of RzeszowCompletedSpine Osteoarthritis | Spa ResortsPoland
-
Charles University, Czech RepublicNot yet recruitingSpinal Muscular Atrophy (SMA)Czechia
-
Connolly Hospital BlanchardstownCompletedOutpatients General Surgery Virtual ClinicIreland
-
PerspectumGE HealthcareCompletedEndometriosis | Reproductive System DisorderUnited Kingdom
-
Quality Living, Inc.Enrolling by invitationBrain Injuries, TraumaticUnited States
-
Yale UniversityCompleted
-
Centre Hospitalier Régional Metz-ThionvilleCompleted